ADMET INSIGHTS

As with many 2020 scientific meetings and events, the Society of Toxicology (SOT) Annual Meeting was canceled as an in-person event due to the ongoing COVID-19 pandemic. However, SOT has organized a robust offering of online content as a replacement. While nothing beats the energy of a live scientific meeting, the virtual format is available to a broader audience of attendees globally. Visit the 2020 SOT Virtual...  Read More

"We must urgently develop measures to tackle the new coronavirus -- but safety always comes first." 1Dr. Shibo Jiang As COVID-19 deaths rise and the world economy continues to take devastating hits, countries, states, and cities are desperate for anything that can provide relief. Dr. Jiang, professor of virology at Fudan University, notes that, "combating this disease demands a vaccine that is safe and potent. The fatality...  Read More

rasH2™ Mouse Supports Short-Term Skin Carcinogenicity Studies A recently published article by Mayumi Kawabe et al. has confirmed the effectiveness of rasH2™ mouse in predicting skin carcinogenicity. The most recent article is a follow-up of an earlier paper published in Veterinary Pathology by Kawabe M, Urano K, et al., which concluded that skin promotion effects could be detected within only eight weeks in the rasH2™ mice, and...  Read More

Cytochromes P450 (CYP) is a superfamily of proteins involved in metabolism and inactivation of foreign substances and toxins. Each protein in this family is highly specialized with unique, dedicated pathways inside the cell. CYPs are transmembrane proteins commonly found in the plasma membrane of the endoplasmic reticulum in liver cells and interact with ligands on both sides1. Using heme as a cofactor, these proteins aid in the...  Read More

The annual Society of Toxicology (SOT) meeting is the largest toxicological meeting in the world. The 57th Annual Meeting and ToxExpo was held in San Antonio, Texas, and drew more than 6,100 scientists from Europe, Africa, Asia, Canada, and almost every state of the United States. This is where scientists go to discover all the advances in toxicology from the past year and to meet with colleagues,...  Read More

The 43rd annual Summer Toxicology forum meeting was held on July 10-12, 2017 in Annapolis Maryland. The afternoon of July 10th was dedicated to a section titled "Use of Humanized Mice for Drug Development". The session was moderated by James Monroe, PhD, senior principle scientist at Merck Research Laboratories, and included presentations by researchers at the FDA, Merck, Yale, and Taconic Biosciences followed by a panel discussion...  Read More

75% of mouse carcinogenicity studies submitted to the FDA utilize the rasH2™ mouse model (Tg.rasH2), a model accepted by the FDA as an alternative to the two-year in vivo bioassay for predicting human carcinogenic risk. In an evolving carcinogenicity testing landscape, with the utility of two-year rat bioassay under re-consideration and changes under consideration to the ICH guidelines for carcinogenic risk assessment, several key questions come to...  Read More

The rasH2™ mouse model is used for carcinogenicity testing of genotoxic and non-genotoxic compounds. Over the last decade, it has become the leading alternative to the traditional 2-year rodent lifetime bioassay. In a recent opinion article, Paranjpe et al. (Paranjpe et al., 2014, Toxicologic Pathology, XX: 1-10), evaluated study design of carcinogenicity studies using the rasH2™ mouse model, particularly with respect to the dose groups of the...  Read More